Prnewswire Abbott News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prnewswire abbott. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prnewswire Abbott Today - Breaking & Trending Today

Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook

/PRNewswire/ Abbott today announced financial results for the fourth quarter ended Dec. 31, 2023.. ....

United States , Prnewswire Abbott , Robertb Ford , Cardiovascular Systems Inc , Tandem Diabetes Care Inc , Acelis Connected Health , Drug Administration , European Union Medical Device Regulations , European Union , Core Laboratory , Abbott Laboratories , Pulsed Field Ablation , Tandem Diabetes Care , Cardiovascular Systems , Pediatric Nutrition , Adult Nutrition , Rapid Diagnostics , Heart Failure , Emerging Markets , Medical Devices , Diabetes Care , Structural Heart , Freestyle Libre , Aristocrats Index , Investor Relations , Private Securities Litigation Reform Act ,

Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign

- Abbott, Real Madrid and the Real Madrid Foundation launch Beat Malnutrition campaign as part of a sustained collaboration urging communities to work. ....

United States , Ann Smith , Prnewswire Abbott , World Health Organization , Training Real Madrid Foundation , Real Madrid Foundation Social Sports Schools , Abbott Center , Malnutrition Solutions , Health Sciences , Real Madrid Foundation , National Health Service , Global Partner Of The Real Madrid Foundation , Abbott World Marathon Majors Global Run Club , Abbott Fund , Real Madrid , Beat Malnutrition , Real Madrid Foundation Social Sports , United Nations , Nutrition Partner , Real Madrid Football Club , Global Partner , Mid Upper Arm Circumference , Athletic Bilbao , Santiago Bernab , Future Well Kids , Discovery Education ,

Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies

/PRNewswire/ Abbott (NYSE: ABT) today announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in. ....

United States , Michael Dale , Feops Heartguide , Abbott Triclip , Prnewswire Abbott , Abbott Mitraclip , Jason Rogers , University Of California , York Heart Association , Davis Medical Center , Cardiovascular Research Foundation , Transcatheter Cardiovascular Therapeutics , Left Atrial Appendage Occluder , New York Heart Association , Functional Class , Kansas City Cardiomyopathy Questionnaire , Davis Medical , Year Outcomes , Boston Scientific , Amplatzer Amulet ,

Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies

/PRNewswire/ Abbott (NYSE: ABT) today announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in. ....

United States , Michael Dale , Feops Heartguide , Abbott Triclip , Prnewswire Abbott , Abbott Mitraclip , Jason Rogers , University Of California , York Heart Association , Davis Medical Center , Cardiovascular Research Foundation , Transcatheter Cardiovascular Therapeutics , Left Atrial Appendage Occluder , New York Heart Association , Functional Class , Kansas City Cardiomyopathy Questionnaire , Davis Medical , Year Outcomes , Boston Scientific , Amplatzer Amulet ,

Abbott Reports First-Quarter 2021 Results

Share this article
Share this article
ABBOTT PARK, Ill., April 20, 2021 /PRNewswire/ Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2021.
First-quarter sales of $10.5 billion increased 35.3 percent on a reported basis and 32.9 percent on an organic basis, which excludes the impact of foreign exchange.
First-quarter GAAP diluted EPS was $1.00 and adjusted diluted EPS, which excludes specified items, was $1.32, reflecting 103.1 percent growth versus the prior year.
1
Abbott projects full-year 2021 diluted EPS from continuing operations on a GAAP basis of at least $3.74. Projected full-year adjusted diluted EPS from continuing operations of at least $5.00 remains unchanged and reflects growth of more than 35 percent versus the prior year. ....

Abbott Binax , Prnewswire Abbott , Robertb Ford , Us Centers For Medicare Medicaid Services , Drug Administration , Core Laboratory Diagnostics , Abbott Laboratories , Core Laboratory , Medicaid Services , Virtual Clinic , Emergency Use Authorization , Self Test , Adult Nutrition , Pediatric Nutrition , Molecular Diagnostics , Emerging Markets , Medical Devices , Diabetes Care , Libre Sense , Freestyle Libre , Generally Accepted Accounting Principles , Aristocrats Index , Investor Relations , Private Securities Litigation Reform Act , Caution Concerning Forward Looking , Annual Report ,